The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Aβ and Tau Toxicities in Alzheimer's Are Linked via Oxidative Stress-Induced P38 Activation: Protective Role of Vitamin E
Open accessAbstract
Oxidative stress is a hallmark of Alzheimer's disease (AD). We propose that rather than causing damage because of the action of free radicals, oxidative stress deranges signaling pathways leading to tau hyperphosphorylation, a hallmark of the disease. Indeed, incubation of neurons in culture with 5 µM beta-amyloid peptide (Aβ) causes an activation of p38 MAPK (p38) that leads to tau hyperphosphorylation. Inhibition of p38 prevents Aβ-induced tau phosphorylation. Aβ-induced effects are prevented when neurons are co-incubated with trolox (the water-soluble analog of vitamin E). We have confirmed these results in vivo, in APP/PS1 double transgenic mice of AD. We have found that APP/PS1 transgenic mice exhibit a high level of P-p38 in the hippocampus but not in cortex and this is prevented by feeding animals with a diet supplemented with vitamin E. Our results underpin the role of oxidative stress in the altered cell signaling in AD pathology and suggest that antioxidant prevention may be useful in AD therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, it has been reported that the Aβ-induced oxidative stress leads to the activation of p38 MAPK and subsequent tau hyperphosphorylation (Giraldo et al., 2014).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Giraldo et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,369
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G. W., Robinson, F. L., Gibson, T. B., Xu, B.-E., Karandikar, M. S., Berman, K. S., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,111
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987 · cited 1×
“Some structures like the hippocampus are very heavily damaged whereas others, like the motor, somatic sensory, and primary visual areas are spared [17].”
BackgroundDysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., et al. (2014) · JAMA · doi:10.1001/jama.2013.282834 · Cited by 628
Alzheimer's disease – do tauists and baptists finally shake hands?
Mudher, A. K., & Lovestone, S. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02031-2 · Cited by 523
Vitamin E for Alzheimer's dementia and mild cognitive impairment
Farina, N., Llewellyn, D. J., Isaac, M. G. E. K. N., & Tabet, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002854.pub5 · Cited by 424
p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis
Dolado, I., Swat, A., Ajenjo, N., Vita, G. D., Cuadrado, A., & Nebreda, Á. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.013 · Cited by 422
Zhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378
p38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · cited 1×
“In Alzheimer’s disease (AD), increased p38 MAPK activity in human brains was observed more than a decade ago [2].”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 277
Quintana, M. T., Parry, T. L., He, J., Yates, C. C., Sidorova, T. N., Murray, K. T., Bain, J. R., Newgard, C. B., Muehlbauer, M. J., Eaton, S. C., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.017 · Cited by 45
Lucke-Wold, B. P., Naser, Z. J., Logsdon, A. F., Turner, R. C., Smith, K. E., Robson, M. J., Bailes, J. E., Lee, J. M., Rosen, C. L., & Huber, J. D. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.005 · Cited by 44
Noor, N. A., Hosny, E. N., Khadrawy, Y. A., Mourad, I. M., Othman, A. I., Ezz, H. S. A., & Mohammed, H. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00897-z · Cited by 45
Chandran, S., & Binninger, D. (2023) · Antioxidants · doi:10.3390/antiox13010021 · Cited by 45
Chilton, P. M., Ghare, S. S., Charpentier, B. T., Myers, S., Rao, A. V., Petrosino, J. F., Hoffman, K. L., Greenwell, J. C., Tyagi, N., Behera, J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2389319 · Cited by 45
Iba, M., Kim, C., Kwon, S., Szabo, M. P., Horan-Portelance, L., Peer, C. J., Figg, W. D., Reed, X., Ding, J., Lee, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6089 · Cited by 42
Dong, S., Huang, X., Zhen, J., Halm‐Lutterodt, N. V., Wang, J., Zhou, C. L., & Yuan, L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1060-6 · Cited by 41
“It has been reported that VE does not biosimilarly function as an antioxidant in all AD patients [39].”
p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia
Lin, H., Dixon, S. G., Hu, W., Hamlett, E. D., Jin, J., Ergul, A., & Wang, G. Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02909-0 · Cited by 43
“Consistent with these findings, previous studies indicated that oxidative stress could induce p38 activation [45, 46].”
ResultUnveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Jha, N. K., Jha, N. K., Nuli, M. V., Gupta, S. K., Kanna, S., Gahtani, R. M., Hani, U., Singh, A. K., Abomughaid, M. M., Abomughayedh, A. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102224 · Cited by 43
Neurotropin® alleviates hippocampal neuron damage through a HIF ‐1α/ MAPK pathway
Fang, W., Zhao, D., Wang, F., Li, M., Fan, S., Liao, W., Zheng, Y., Liao, S., Xiao, S., Luan, P., et al. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12689 · Cited by 42
Rehman, I., Ahmad, R., Khan, I., Lee, H. J., Park, J., Ullah, R., Choi, M. J., Kang, H. Y., & Kim, M. O. (2021) · Biomedicines · doi:10.3390/biomedicines9040408 · Cited by 47
RetractedNon-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 51
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40
“Ahmed (2012), tested the treatment of vitamin E, acetyl-L-carnitine, and alpha-lipoic acid on AD induced rats [53].”
BackgroundMitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential
Mi, Y., Qi, G., Brinton, R. D., & Yin, F. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8070 · Cited by 43
“In multiple AD mouse models, vitamin E administration alleviated memory deficits, oxidative stress, Tau hyperphosphorylation, and amyloid deposition (57).”
BackgroundSystemic health effects of noise exposure
Yang, L., Gutierrez, D. E., & Guthrie, O. W. (2023) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2023.2280837 · Cited by 47
“In addition, Aβ might also trigger GSK3β kinase activation and lead to p-Tau formation (Giraldo et al. 2014).”
BackgroundModulating Effect of Diet on Alzheimer’s Disease
Fernández-Sanz, P., Ruiz-Gabarre, D., & García‐Escudero, V. (2019) · Diseases · doi:10.3390/diseases7010012 · Cited by 41
Ashley, S., Bradburn, S., & Murgatroyd, C. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1681066 · Cited by 42
“The APOE ε4 allele is associated with an increased risk of AD [18].”
BackgroundInfluentialEffects of vitamin E on neurodegenerative diseases: an update
İçer, M. A., Arslan, N., & Karadağ, M. G. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-003 · Cited by 44
“Vitamin E inhibits activation of p38 by hindering oxidative stress, and thus prevents phosphorylation of tau proteins (Giraldo et al., 2014).”
BackgroundInfluentialPorphyromonas gingivalis: a potential trigger of neurodegenerative disease
Huang, Z., Hao, M., Shi, N., Wang, X., Lin, Y., Yuan, H., & Wang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1482033 · Cited by 44
“And phosphorylated tau proteins contribute to AD by causing microtubule rupture, synaptic loss, and, ultimately, cognitive dysfunction (64, 65).”
Association of vitamin E intake in diet and supplements with risk of dementia: A meta-analysis
Zhao, R., Han, X., Zhang, H., Liu, J., Zhang, M., Zhao, W., Jiang, S., Li, R., Cai, H., & You, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.955878 · Cited by 41
“Vitamin E is an antioxidant that can reduce the risk of dementia onset (Giraldo et al., 2014; Eshkoor et al., 2015; Farina et al., 2017; Lakhan et al., 2021).”
BackgroundVitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?
Cervantes, B. R., & Ulatowski, L. M. (2017) · Antioxidants · doi:10.3390/antiox6030045 · Cited by 37
Nutrition: Review on the Possible Treatment for Alzheimer’s Disease
Botchway, B. O. A., Moore, M. K., Akinleye, F. O., Iyer, I. C., & Fang, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170874 · Cited by 38
Mosaferi, B., Jand, Y., & Salari, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-02231-0 · Cited by 37
Lin, C.-I., Chang, Y.-C., Kao, N.-J., Lee, W., Cross, T.-W., & Lin, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124215 · Cited by 34
“Excess generation of ROS has been shown to play a crucial role in the mechanisms associated with Aβ-induced neurotoxicity as well as tau pathology [34,35].”
BackgroundChen, Y., Huang, X., Chen, W., Wang, N.-Q., Wu, X.-L., & Liu, Y. (2018) · Brain Circulation · doi:10.4103/bc.bc_2_17 · Cited by 33
“Brain Circulation ‐ Volume 4, Issue 1, January‐March 2018 25 tau hyperphosphorylation, and β-amyloid (Aβ) overexpression.[3-5]”
Ding, H., Reiss, A. B., Pinkhasov, A., & Kasselman, L. J. (2022) · Medicina · doi:10.3390/medicina58081025 · Cited by 32
“Furthermore, tocopherol and tocotrienols have been shown to have an inhibitory effect on enzymes that contribute to neuroinflammation in Alzheimer’s disease [120].”
BackgroundNutritional supplementation for Alzheimerʼs disease?
Shea, T. B., & Remington, R. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000138 · Cited by 32
“protein (MAP) kinase that otherwise led to tau hyperphosphorylation in preclinical studies [27].”
BackgroundImpact of Nut Consumption on Cognition across the Lifespan
Nishi, S. K., Sala‐Vila, A., Júlvez, J., Sabaté, J., & Ros, E. (2023) · Nutrients · doi:10.3390/nu15041000 · Cited by 33
“Finally, in a study including both in vitro (primary culture of cortical neurons) and in vitro (APP/PS1 double transgenic mice of AD), exposure to vitamin E reduced the formation of hyperphosphorylated tau through the inhibition of p38MAPK [107].”
BackgroundAbdel-Rafei, M. K., & Thabet, N. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118410 · Cited by 30
Işık, S., Alhelwani, S., Sahsahi, A., Balcilar, H., & Yeman-Kıyak, B. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01955-0 · Cited by 33
“Gluta-mate excitotoxicity on the other hand is a hallmark of various neurological diseases and is mediated by dysregulation of calcium signaling pathway [124].”
He, L., & Sun, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00762-z · Cited by 30
Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 29
Antioxidant Vitamins and Brain Dysfunction in Alcoholics
González‐Reimers, E., Fernández-Rodríguez, C. M., Martín-González, M. C., Hernández-Betancor, I., Abreu-González, P., de la Vega-Prieto, M. J., Elvira-Cabrera, O., & Santolaria-Fernández, F. J. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt150 · Cited by 28
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 30
Guarnieri, L., Bosco, F., Leo, A., Citraro, R., Palma, E., Sarro, G. D., & Mollace, V. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102210 · Cited by 28
“…this finding, in a mouse model, it has been seen that the deficiency of Vit E was associated with a greater expression of genes involved in AD progression, including also those involved in the regulation of apoptosis, neurotransmission, and A β metabolism (Tan et al., 2016; Giraldo et al., 2014).”
BackgroundMethodAlam, P., Siddiqi, M. K., Malik, S., Chaturvedi, S. K., Uddin, M., & Khan, R. H. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.134 · Cited by 26
Moyano, P., Garcia, J., García, J., Anadon, M., Naval, M., Frejo, M., Sola, E., Pelayo, A., & del Pino, J. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110975 · Cited by 22
Proteogenomics of the human hippocampus: The road ahead
Kang, M., Byun, K., Kim, J. H., Park, N. H., Heinsen, H., Ravid, R., Steinbusch, H. W. M., Lee, B., & Park, Y. M. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.02.010 · Cited by 27
del Pino, J., Moyano, P. M., Díaz, G. G., Anadón, M. J., Díaz, M. J. V., García, J. M., Lobo, M., Pelayo, A., Solà, E., & Frejo, M. T. (2017) · Toxicology · doi:10.1016/j.tox.2017.09.008 · Cited by 25
“…they have been related with the alteration of AChE splice variants and GSK-3β gene expression, Aβ production and Tau abnormal phosphorylation (Bond et al. 2006; Giraldo et al. 2014; Rojo et al. 2008; Tamagno et al. 2005; Wang et al. 2009), which could also contribute to explain the effect observed.”
Backgrounddel Pino, J., Moyano, P. M., Anadón, M. J., García, J. M., Díaz, M. J. V., García, J., & Frejo, M. T. (2015) · Toxicology · doi:10.1016/j.tox.2015.07.004 · Cited by 25
Zadeh, F. N., Nazari, M., Amini, A., Adeli, S., Behrooz, A. B., & Fahanik‐Babaei, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1073369 · Cited by 24
“Consistent with our data, it has been shown that administration of α-Tocopherol could reduce oxidative stress in SH-SY5Y neuroblastoma cells following amyloid-beta exposure and, so, can reduce the cytotoxicity induced by Aβ treatment (Giraldo et al., 2014).”
ResultSelected Micronutrients in Cognitive Decline Prevention and Therapy
Visioli, F., & Burgos‐Ramos, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9349-1 · Cited by 24
Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition
Grizzanti, J., Corrigan, R. R., & Casadesús, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180433 · Cited by 24
The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects
Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Fawzy, M. N., Papadakis, M., Al-Botaty, B. M., Alruwaili, M., & Batiha, G. E. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177510 · Cited by 27
Zolkiffly, S. Z. I., Stanslas, J., Hamid, H. A., & Mehat, M. Z. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114309 · Cited by 23
Zhang, J., Li, H., Zhang, Y., Zhao, C., Zhu, Y., & Han, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020427 · Cited by 23
“p38-α (MAPK14) mediates oxidative stress and leads to the aggregation of the tau protein [39].”
BackgroundMechanistic insights into procyanidins as therapies for Alzheimer's disease: A review
Ruan, W., Shen, S.-H., Xu, Y., Ran, N., & Zhang, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104683 · Cited by 23
Alrouji, M., Alshammari, M. S., Syed, T., & Shamsi, A. (2025) · Antioxidants · doi:10.3390/antiox14070774 · Cited by 21
“Tau hyperphosphorylation results from ROS-activating p38 mitogen-activated protein kinase (p38 MAPK) [174]. p38 MAPK has been linked to neuroinflammation and AD due to its ability to activate NF-κ B in the brains of AD patients [175–177].”
Pal, S., & Melnik, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-11242-4 · Cited by 22
Role of Vitamin E in Neonatal Neuroprotection: A Comprehensive Narrative Review
Kolnik, S. E., & Wood, T. R. (2022) · Life · doi:10.3390/life12071083 · Cited by 22
Hu, M., Kang, X., Liu, Z., Wang, S., Liu, S., Li, C., Lu, D., Qin, Q., Liu, Y., Yi, H., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00956-5 · Cited by 21
Tang, S., Zhang, Y., Botchway, B. O. A., Wang, X., Huang, M., & Liu, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04498-6 · Cited by 23
CD2AP deficiency aggravates Alzheimer’s disease phenotypes and pathology through p38 MAPK activation
Xue, Y., Zhang, Z.-S., Lin, R.-R., Huang, H.-F., Zhu, K., Chen, D.-F., Wu, Z., & Tao, Q. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00454-5 · Cited by 22
“A previous study reported that 9-month-old APP/PS1 mice exhibit increased levels of phosphorylated p38 (p-p38) in the hippocampus but not in the cortex [42].”
Tauopathies: Mechanisms and Therapeutic Strategies
Tan, C., Zhang, X.-Y., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170187 · Cited by 21
The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
Knight, E., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · Metabolites · doi:10.3390/metabo13030438 · Cited by 20
“Vitamin E supplementation also reduced p38 activation but not tau phosphorylation in the hippocampus of APP/PS1 mice [158].”
BackgroundLi, X., Gu, Y., Ma, L., Bai, X., Jie, J., Zhang, X.-F., & Chen, D. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238621 · Cited by 19
“Numerous studies have shown that the MAPK signaling pathway plays a major role in the pathophysiology of AD (Giraldo et al., 2014; Petrov et al., 2016; Lee and Kim, 2017).”
BackgroundJahanshahi, M., Nikmahzar, E., & Sayyahi, A. (2020) · PubMed · doi:10.22038/ijbms.2019.38165.9067 · Cited by 19
“Furthermore, in vitro experiment revealed that the incubation of cultured neurons with beta-amyloid peptide increases the expression of phosphorylated tau, which Trolox can prevent (33).”
BackgroundInfluentialPolis, B., Srikanth, K. D., Gurevich, V., Bloch, N., Gil-Henn, H., & Samson, A. O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031133 · Cited by 19
“This kinase has been shown to be activated via β-amyloid peptide and induce Tau protein hyperphosphorylation [55].”
BackgroundOladele, J. O., Oladiji, A. T., Oladele, O. T., & Oyeleke, O. M. (2021) · Biochemistry · doi:10.5772/intechopen.99976 · Cited by 21
Bignante, E. A., Ponce, N. E., Heredia, F., Musso, J., Krawczyk, M. C., Millan, J., Pigino, G. F., Inestrosa, N. C., Boccia, M. M., & Lorenzo, A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.013 · Cited by 17
“Previous reports showed activation of p38-MAPK by Aβ (Giraldo et al., 2014) and increased p38-MAPK activity in AD (Zhu et al., 2000).”
BackgroundMi, L., Fan, M., Liu, T., Wu, D., Wang, Y., Li, F., Cai, Y., Qiu, Z., Liu, D., & Cao, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1074397 · Cited by 18
Cowan, C. M., Sealey, M. A., & Mudher, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15253 · Cited by 17
“Drug doses were selected based on previous studies that utilized these drugs (Dias-Santagata et al., 2007; Giraldo et al., 2014; Harrison et al., 2009).”
BackgroundMethodSynthesis of benzopyran derivatives as PPARα and/or PPARγ activators
Bermejo, A., Barrachina, I., Aouad, N. E., Franck, X., Chahboune, N., Andreu, I., Figadère, B., Vila, L., Hennuyer, N., Staels, B., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115162 · Cited by 16
Iannucci, J., Johnson, S. L., Majchrzak, M., Barlock, B. J., Akhlaghi, F., Seeram, N. P., Sen, A., & Grammas, P. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100862 · Cited by 16
Moyano, P. M., Sanjuan, J., García, J. M., Anadón, M. J., Lobo, M., Pelayo, A., García, J., Frejo, M. T., & del Pino, J. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110961 · Cited by 16
Zhao, L., Xiao, Y. C., Xiu, J., Tan, L.-C., & Guan, Z. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.020 · Cited by 15
Jabeen, K., Rehman, K., Akash, M. S. H., Nadeem, A., & Mir, T. M. (2023) · Biomedicines · doi:10.3390/biomedicines11092453 · Cited by 14
Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
Huang, D., Liao, W., Li, J., Chen, T., Wang, X., Zhao, R., Zhang, L., Yu, X., Zheng, D., & Luan, P. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302015 · Cited by 15
Hosseini, A., Sheibani, M., & Valipour, M. (2024) · Phytotherapy Research · doi:10.1002/ptr.8329 · Cited by 14
Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results
Viña, J., Borrás, C., & Mas‐Bargues, C. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.051 · Cited by 15
Stelmashook, E. V., Генрихс, Е. Е., Рафаилевна, К. М., Андреевна, З. Е., & Исаев, Н. К. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917100108 · Cited by 14
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Almasoudi, S. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Eliwa, D., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111296 · Cited by 16
“In addition, MET have pleiotropic AMPK-dependent and independent effects through inhibition of inflammation, oxidative stress and athero-thrombosis (Al-Kuraishy et al., 2022; Al-kuraishy et al., 2023a; Al-Kur-aishy et al., 2023c).”
Phytopharmaceuticals and Herbal Approaches to Target Neurodegenerative Disorders
Islam, A., Mishra, A., Ahsan, R., & Fareha, S. (2023) · Drug Research · doi:10.1055/a-2076-7939 · Cited by 13
Hussien, H. M., Ghareeb, D. A., Ahmed, H. E. A., Hafez, H. S., & Saleh, S. R. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15193-7 · Cited by 12
“In fact, a closed relation was detected between the induction of oxidative stress and the elevation of Aβ42 level and overexpression of APP and tau protein confirming the deleterious role of oxidative stress in the oligomerization of toxic Aβ and NFT formation (Giraldo et al. 2014).”
BackgroundAcetaldehyde induces tau phosphorylation via activation of p38 MAPK/JNK and ROS production
Li, T., Shi, H., & Zhao, Y. (2021) · Molecular & Cellular Toxicology · doi:10.1007/s13273-021-00193-y · Cited by 13
Xia, M., Liu, Q., Zhang, W., Ge, J., & Mei, Z. (2025) · MedComm · doi:10.1002/mco2.70328 · Cited by 15
“In neuronal and glial cell subpopulations coexpressing lncRNA-Snhg14 , Mrtfa , and Mrtfb , calcium signaling and mitogen-activated protein kinase (MAPK) pathways were found to be significantly enriched, which have been previously linked to A β plaque generation [159].”
Rezk, S., Lashen, S., El‐Adl, M., Elshopakey, G. E., Elghareeb, M. M., Hendam, B. M., Caceci, T., Cenciarelli, C., & Marei, H. E. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00890-6 · Cited by 12
RetractedJiyah, A., Muhammad, S. A., Ibrahim, A., Bulama, I., Ibrahim, A., Abbas, A. Y., Imam, M. U., Saidu, Y., & Bilbis, L. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105618 · Cited by 13
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 12
Neuroprotective effects of ZL006 in Aβ1–42-treated neuronal cells
Tao, W., Yu, L., Jiang, S., Cao, X., Chen, J., Bao, X.-Y., Li, F., Xu, Y., & Zhu, X.-L. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.285006 · Cited by 12
“In addition, Aβ-induced oxidative stress contributes to the pathology of tau phosphorylation by activating the JNK/ p38 mitogen-activated protein kinase pathway, suggesting the association between oxidative stress and tau hyperphosphorylation (Giraldo et al., 2014).”
BackgroundXie, J., Lan, Y., Zou, C., He, J., Huang, Q., Zeng, J., Pan, M., Mei, Y., Luo, J., & Zou, D. (2024) · BMC Genomics · doi:10.1186/s12864-024-10447-3 · Cited by 12
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 11
“Similarly, overactivated P38 has been shown to increase tau phosphorylation and favor amyloidogenic processing of the amyloid precursor protein (APP), while inhibition of JNK by D-JNKI1 is suggested to suppress synaptic shrinkage in AD patients [149,151,152].”
Owens, L., Benedetto, A., Dawson, N., Gaffney, C. J., & Parkin, E. T. (2021) · Brain Research · doi:10.1016/j.brainres.2020.147264 · Cited by 11
del Pino, J., Zeballos, G., Anadón, M. J., Díaz, M. J. V., Moyano, P. M., Díaz, G. G., García, J., Lobo, M., & Frejo, M. T. (2016) · Toxicology · doi:10.1016/j.tox.2016.06.019 · Cited by 11
Makori, W. A., Kibiti, C. M., Njagi, J. M., & Ngugi, M. P. (2019) · Neural Plasticity · doi:10.1155/2019/2867058 · Cited by 11
“Moreover, the reduction of oxidative stress by vitamin E protects against phosphorylation of Aβ-induced tau through the inhibition of the activation of p38-MAPK [89].”
BackgroundWu, D., Wen, Y., Zhao, Y., Wei, Y., Liu, L., Yan, Q., Yu, C., Liu, J.-Y., Zhu, X.-X., Zhong, Z.-G., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03850-6 · Cited by 10
Özdemir, A. Y., Çetin, E. A., Novotný, J., & Rudajev, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118157 · Cited by 12
The Role of Vitamin E in Slowing Down Mild Cognitive Impairment: A Narrative Review
Lakhan, R., Sharma, M., Batra, K., & Beatty, F. (2021) · Healthcare · doi:10.3390/healthcare9111573 · Cited by 10
“Giraldo et al. 2014 In vivo, mice study The effect of Vitamin E was observed on the inhibition of p38 which prevents Aβ-induced tau phosphorylation that leads to cognitive impairment.”
BackgroundXia, L.-Y., Tang, L., Huang, H., & Luo, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.752858 · Cited by 11
Umukoro, S., Okoh, L., Igweze, S. C., Ajayi, A. M., & Ben‐Azu, B. (2020) · Drug metabolism and drug interactions · doi:10.1515/dmpt-2020-0112 · Cited by 10
Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer’s Disease Patients
Watson, C. N., Begum, G., Ashman, E., Thorn, D., Yakoub, K. M., Hariri, M. A., Nehme, A., Mondello, S., Kobeissy, F. H., Belli, A., et al. (2022) · Cells · doi:10.3390/cells11010163 · Cited by 12
Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders
Singh, S. K., Ahuja, A., & Pathak, S. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073280680240101065732 · Cited by 10
Moreno, R., Recio, J., Barber, S., Gil, C., & Martínez, A. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115511 · Cited by 10
CAR Treg therapies for neurodegenerative diseases
Stein, D. N., & Gendelman, H. E. (2026) · iScience · doi:10.1016/j.isci.2026.114988 · Cited by 8
Effect of Vitamin E on Transcriptomic Alterations in Alzheimer’s Disease
Ekeuku, S. O., Murshid, N. M., Shukri, S. N., Sahardi, N. F. N. M., & Makpol, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512372 · Cited by 9
“In addition to its antioxidant capabilities, vitamin E has been found to have a variety of qualities that can modify cell signaling pathways [64].”
BackgroundMKP ‐1 regulates the inflammatory activation of microglia against Alzheimer's disease
Li, J., Wang, L., Zeng, Q., He, J., Tang, Q., Wang, K., & He, G. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14409 · Cited by 8
“25,56 The activation of p38 activation in the presence of A β also contributes to the phosphorylation of tau 57 and facilitates the amyloidogenic processing of APP.”
BackgroundProtective role and related mechanism of Gnaq in neural cells damaged by oxidative stress
Jia, N., Li, G., Huang, P., Guo, J., Wei, L.-G., Lu, D., & Chen, S. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx024 · Cited by 8
Chen, Y., Zhu, L., Ji, L., Yang, Y., Lu, L., Wang, X., & Zhou, G. (2018) · Medical Science Monitor · doi:10.12659/msm.912862 · Cited by 8
“We were particularly interested in the MAPK signaling pathway, which is known to be involved in the transcriptional regulation of several genes encoding for proinflammatory cytokines, and their altered phosphorylation states may lead to the development of inflammatory response in AD [19,20].”
BackgroundClioquinol rescues yeast cells from Aβ42 toxicity via the inhibition of oxidative damage
Zheng, Q., Zhu, H., Lv, C., Zhu, Z., Cui, H., Fan, Z., Sun, J., Huang, Z., & Shi, P. (2024) · Biotechnology Journal · doi:10.1002/biot.202300662 · Cited by 7
“[29,30] Regarding that CQ could rescue yeast cells from A β 42 toxicity, we speculated that CQ might protect the A β 42 strain from oxidative damage.”
BackgroundGiudici, K. V., Barreto, P. D. S., Guyonnet, S., Cantet, C., Zetterberg, H., Boschat, C., Hudry, J., Andrieu, S., Schmitt, J. A. J., Vellas, B. J., et al. (2023) · Journal of Aging Research and Lifestyle · doi:10.14283/jarlife.2023.7 · Cited by 7
“Vitamin E has been reported to prevent Aβ-induced tau phosphorylation both in vitro and in APP/PS1 transgenic mice, by inhibiting p38MAPK phosphorylation (50).”
Background
Metadata
- Authors
- Giraldo, E., Lloret, A., Fuchsberger, T., & Viña, J.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Viña, J.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2014
- Volume
- 2
- Pages
- 873-877
- ISSN
- 2213-2317 (ISSN-L)
- PMC
- PMC4099506
- OpenAlex
- W2039173359
- Cited by
- 268
- References
- 28
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 23 · 2023: 34 · 2022: 27 · 2021: 26 · 2020: 27 · 2019: 24 · 2018: 22 · 2017: 21 · 2016: 12 · 2015: 19 · 2014: 3
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Redox Biology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Spanish Ministry of Education and Science (MEC) (SAF2010-19498)
- “Red Tematica de investigacion cooperativa en envejecimiento y fragilidad” (RETICEF) (ISCIII2006-RED13-027, ISCIII2012-RED-43-029)
- “Conselleria d’Educació, Cultura i Esport de la Generalitat Valenciana” (PROMETEO2010/074)
- “Fundació Gent Per Gent de la Comunitat Valenciana” (35NEURO)
- INCLIVA (RS2012-609)
- EU (CM1001, FRAILOMIC-HEALTH.2012.2.1.1-2)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- Alzheimer's disease, amyloid-beta, tau hyperphosphorylation, oxidative stress, p38 MAPK, vitamin E, Trolox, APP/PS1 mice, hippocampus, antioxidant therapy, neuronal signaling
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Disease Models, Animal, Hippocampus, Male, Mice, Transgenic, Neurons, Phosphorylation, Vitamin E, Amyloid beta-Peptides, tau Proteins, Oxidative Stress, Protective Agents, p38 Mitogen-Activated Protein Kinases, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review